Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Earnings Scheduled For May 10, 2022
Companies Reporting Before The Bell
• The Middleby (NASDAQ:MIDD) is expected to report quarterly earnings at $2.10 per share on revenue of $935.99 million.
Recap: InspireMD Q4 Earnings
InspireMD (NASDAQ:NSPR) reported its Q4 earnings results on Tuesday, March 8, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
InspireMD Q4 EPS $(0.53) Beats $(0.78) Estimate, Sales $1.38M Beat $1.30M Estimate
InspireMD (AMEX:NSPR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.78) by 32.05 percent. This is a 64.67 percent increase over losses of $(1.50) per share from the same
Earnings Scheduled For March 8, 2022
Companies Reporting Before The Bell
• Babcock & Wilcox (NYSE:BW) is likely to report quarterly earnings at $0.10 per share on revenue of $196.62 million.
Preview: InspireMD’s Earnings
InspireMD (AMEX:NSPR) is set to give its latest quarterly earnings report on Tuesday, 2022-03-08. Here's what investors need to know before the announcement.
Analysts estimate that InspireMD will report an earnings per share (EPS) of $-0.78.
The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg
Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in four out of five sessions of the week.
InspireMD Announces The Inclusion Of Its CGuard Carotid Stent In CREST-2 Trial Following FDA Approval Of The Investigational Device Exemption Supplement Application
InspireMD, Inc. (NASDAQ:NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease and stroke prevention, today announced its CGuard Carotid
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.